Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763683 · ClinicalTrials.gov registry record
Investigations of Dementia in Parkinson Disease
A clinical trial of Parkinsons, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT02763683: Recruiting study of Parkinsons, sponsored by Washington University School of Medicine.
NCT02763683 is a study of Parkinsons that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 320 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02763683, a study of Parkinsons, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.
Primary Outcome
The investigators will perform memory/thinking testing, Lumbar puncture (LP), Magnetic Resonance Imaging (MRI) and (PET) scans to help to determine the cause(s) of memory and thinking in Parkinson Disease. The memory and thinking testing by phone on average at 1.5 years through study completion and then in person on average at 3 years through study completion, this will help monitor if there is any decline in memory and thinking. The Lumbar Puncture is done on willing participants on average a
Conditions Studied
Interventions
- RADIATION PiB and VAT
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2016-06 |
| Est. Completion | 2030-03 |
What NCT02763683 shows while recruiting
NCT02763683 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Parkinsons appearing as the primary indexed condition, and to 1 intervention - of which PiB and VAT is the first listed.
NCT02763683 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02763683 about?
NCT02763683 is a clinical study titled "Investigations of Dementia in Parkinson Disease". The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify in...
What is the current status of trial NCT02763683?
This trial is currently recruiting. The enrollment target is 320 participants. The study started on 2016-06. Estimated completion is 2030-03.
What conditions does trial NCT02763683 study?
This clinical trial studies the following conditions: Parkinsons.
What interventions are being tested in trial NCT02763683?
The interventions under investigation include: PiB and VAT (RADIATION).
Who is sponsoring clinical trial NCT02763683?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02763683 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- NCT04606446 · 320 participants · Phase 1
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia